Ticlopidine versus aspirin after myocardial infarction (STAMI) trial

Journal of the American College of Cardiology

Volumn 37, Issue 5, 2001, Pages 1259-1265

  Scrutinio, Domenico ^a   Cimminiello, Claudio ^b   Marubini, Ettore ^c   Pitzalis, Maria Vittoria ^d   Di Biase, Matteo ^e   Rizzon, Paolo ^c  

^a IRCCS   (Italy)

^b DESIO HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STROKE;

ADULT; AGED; ASPIRIN; CAUSE OF DEATH; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TICLOPIDINE;

EID: 0035312593     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01164-0     Document Type: Article

References (34)

1. Collaborative overview of randomized trials of anti-platelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged anti-platelet therapy in various categories of patients
2. Aspirin as an antiplatelet drug
3. Antiplatelet treatment with ticlopidine in unstable angina: A controlled multicenter clinical trial
4. Prevention of aorto-coronary bypass graft occlusion: Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: A double blind study
5. A randomized comparison of antiplatelet and anticoagulant therapy after placement of coronary-artery stents
6. American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of patients with acute myocardial infarction: A report of the ACC/AHA Task Force on Practice Guidelines
7. Oral inhibitors of platelet membrane receptor glycoprotein IIb/IIIa in clinical cardiology: Issues and opportunities
8. Toward a new frontier in myocardial reperfusion therapy: Emerging platelet prominence
9. Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes
10. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
11. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
12. A prospective placebo-controlled double-blind multicenter trial of Intravenous Streptokinase in Acute Myocardial infarction (ISAM): Long-term mortality and morbidity
13. Effects of alteplase in acute myocardial infarction: 6-month results from ASSET study
14. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: Results of the GISSI-2 data base
15. One-year results of the Thrombolysis In Myocardial Infarction (TIMI) investigation phase II trial
16. A class of K-sample tests for comparing the cumulative incidence of a competing risk
17. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
18. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis: Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI-2) data base
19. A randomized, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ichemic Events (CAPRIE)
20. Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival
21. Improved survival after thrombolysis in acute myocardial infarction
22. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: Incidence and effect of smoking
23. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: Effect of antiplatelet therapy
24. Reocclusion: The flip side of coronary thrombolysis
25. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: Angiographic results of the APRICOT study
26. Optimal management of acute myocardial infarction at the dawn of the next millennium
27. Blood flow and antithrombotic drug effects
28. Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries
29. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear-induced stent thrombosis
30. Platelet inhibitors in cardiovascular disease: An update
31. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries
32. Clopidogrel: A platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions